IL-38 serum levels in patients with Behcet’s disease and the relationship with clinical features
European Cytokine Network · 2019
DOI: 10.1684/ecn.2019.0430 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Cytokine Network, 2019. Verfasst von Maryam Zarrabi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Autoimmune Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran. Die Arbeit wurde bisher 17-mal zitiert (Crossref) und nennt 44 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Autoimmune Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran.
- Division of Rheumatology, Department of Internal Medicine, Shiraz University of Medical Sciences, Shiraz, Iran.
- Autoimmune Diseases Research Center, Shiraz University of Medical Sciences, Shiraz, Iran, Immunology Department, Shiraz University of Medical Sciences, Shiraz, Iran.
Zitieren
APA
Zarrabi, M., Gholijani, N., Shenavandeh, S., Aflaki, E., & Amirghofran, Z. (2019). IL-38 serum levels in patients with Behcet’s disease and the relationship with clinical features. European Cytokine Network. https://doi.org/10.1684/ecn.2019.0430
Vancouver
Zarrabi M, Gholijani N, Shenavandeh S, Aflaki E, Amirghofran Z. IL-38 serum levels in patients with Behcet’s disease and the relationship with clinical features. European Cytokine Network. 2019. doi:10.1684/ecn.2019.0430
BibTeX
@article{Zarrabi2019,
author = {Zarrabi, Maryam and Gholijani, Nasser and Shenavandeh, Saeedeh and Aflaki, Elham and Amirghofran, Zahra},
title = {IL-38 serum levels in patients with Behcet’s disease and the relationship with clinical features},
journal = {European Cytokine Network},
year = {2019},
doi = {10.1684/ecn.2019.0430}
}
EUVIMED